Despite the progress achieved over the last two decades in the field of therapeutic immunosuppression, immune-mediated destruction of allograft (aka chronic rejection) remains among the first causes of late failure. A better understanding of the mechanisms involved first in allorecognition and then in generating graft damages and allograft fibrosis, appears as a mandatory step to design future innovative therapeutic strategies with the potential to improve long-term outcomes.

This Special Issue of Transplant International gathers the best international experts to propose a synthesis of the latest advances in transplant immunology in the field of chronic rejection immunopathology.


Important
As a Gold open-access journal, all submissions are subject to publishing fees. Fee solutions are available on a case-by-case basis, including discounts for ESOT members, Institutional Agreements, and authors from low- and middle-income countries. Please contact the editorial office if you have any questions: ti@frontierspartnerships.org.

Please see the following pages for:
Publishing Fees
Author Guidelines

Article types and fees

This Special Issue accepts the following article types, unless otherwise specified in the Special Issue description:

• Brief Research Report
• Consensus Report
• Editorial
• Executive Summary
• Forum
• Guidelines
• In Memoriam
• Letter to the Editor
• Meeting Report
• ... View all formats

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Article types

This Special Issue accepts the following article types, unless otherwise specified in the Special Issue description:

• Brief Research Report
• Consensus Report
• Editorial
• Executive Summary
• Forum
• Guidelines
• In Memoriam
• Letter to the Editor
• Meeting Report
• Mini Review
• News and Views
• Original Research
• Point of View
• Position Paper
• Protocol
• Registry Report
• Review
• Special Article
• Statistical Insights
• Systematic Review and Meta-Analysis
• Transplant Trial Watch

Keywords: allograft, immunosuppression, allorecognition, allograft fibrosis